software and analytics helped to create high-efficiency dual system imaging sequencers that could double the output without changing the cost of preparing a flow cell. Illumina has contributed to ...

Illumina, Inc. (NASDAQ ... delivering the NovaSeq X single-flow-cell system alongside a cutting-edge software upgrade and new kits.

The combination of Illumina's Single Cell Prep, NovaSeq™ X Plus platform, 25B flow cell and DRAGEN™ analysis software creates a seamless end-to-end workflow enabling the high-throughput ...

Illumina's technology suite, including the NovaSeq™ X Plus platform, 25B flow cell, and DRAGEN™ analysis software, is designed to create an efficient end-to-end workflow for high-throughput ...

Key players in the single-cell analysis market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), BD (US), ...

Industry Prospects Favor Illumina Per a Grand View Research report, the global single-cell analysis market size was valued at $4.34 billion in 2023 and is projected to witness a CAGR of 18.7% from ...

It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation ...

Illumina said it will continue expanding its multiomics portfolio “with new roadmap technologies spanning genomics, spatial, single cell, and methylation, as well as a new multimodal data ...

Illumina will seek to cut $100 million in expenses ... as well as plans to span single-cell analysis, CRISPR, epigenetics research and more.

It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation ...

It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation ...